🇺🇸 FDA
Pharmaceutical Compliance Congress pharmaceutical event banner
← Back to Events
REGULATORY CONCLUDED

Pharmaceutical Compliance Congress

Conference addressing life sciences compliance, enforcement trends, and regulatory frameworks.

Ritz-Carlton, Tysons Corner, McLean, USA April 27 – April 28, 2026
All Events

Coverage & Analysis

6 articles

LIVE COVERAGE

Apr 28
BREAKING Pharma Compliance Congress: Key Takeaways Day 1
Apr 27
BREAKING Pharma Compliance Congress: Key Regulatory Updates Day 1
Apr 27
BREAKING Pharma Compliance Congress: Day 1 Key Regulatory Updates
Apr 27
BREAKING Pharma Compliance Congress 2026 Opens: Key Regulatory Themes

PRE-EVENT

Apr 22
Pharma Compliance Congress 2026: Enforcement Trends & DOJ Insights

POST-EVENT

Apr 29
Pharma Compliance Congress: Annex 1 Challenges & Solutions

🇺🇸 Latest Americas News

All news →
May 5 Palvella Therapeutics Begins Phase 2 Trial of QTORIN Rapamycin for Rare Angiokeratomas May 5 Neurocrine Biosciences Begins Phase 1 Trial of NBIP-2118 for Obesity Treatment May 5 CAPLYTA (Lumateperone) Ranks Highest Among FDA-Approved Adjunctive Depression Treatments in Network Meta-Analysis May 5 Cellenkos Receives FDA Clearance for CK0802 Phase 2a Trial in Steroid-Refractory GVHD May 5 Cellenkos Receives FDA Clearance for CK0802 Phase 1b/2a Trial in Steroid-Refractory GVHD

More from NovaPharmaNews

Event Resources

Explore by Topic